ArticleTranslational oncology2026

Integrated histopathology-transcriptomic biomarker enhances survival prediction in HNSCC patients treated with immunotherapy.

Merzu Belete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.